1-1 of 1
Lorna Fang
Close
Sort by
Journal Articles

Exposure-Response Of Idelalisib, a Novel PI3Kδ Inhibitor, Administered As Monotherapy In The Treatment Of Hematologic Malignancies

Feng Jin, PhD, Huafeng Zhou, PhD, Lorna Fang, Xiaoming Li, PhD, Terry Newcomb, MD, Roger Dansey, MD, Srini Ramanathan, PhD
Journal: Blood
Blood (2013) 122 (21): 5054.
https://doi.org/10.1182/blood.V122.21.5054.5054
Published: 2013